• 1
    Chu P, Wu E, Weiss ML. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000; 13: 962972.
  • 2
    Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992; 140: 427447.
  • 3
    Chhieng CD, Cangiarella FJ, Zakowski FM, Goswami S, Cohen JM, Yee HT. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer (Cancer Cytopathol). 2001; 93: 330336.
  • 4
    van Niekerk CC, Jap PH, Ramaekers FC, van de Malengraft F, Poels LG. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol. 1991; 165: 145152.
  • 5
    Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 1995; 3: 99107.
  • 6
    Kaufmann O, Deidesheimer T, Muehlenberg M, Deick P, Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology. 1996; 29: 233240.
  • 7
    Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996; 56: 860865.
  • 8
    Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin family localized to chromosome 11q3. Oncogene. 1998; 16: 817824.
  • 9
    Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999; 59: 30283031.
  • 10
    Leygue E, Snell L, Dotwzlaw H, et al. Mammaglobin, a potential marker of breast cancer metastasis. J Pathol. 1999: 189: 2833.
  • 11
    Aihara T, Fujiwara Y, Ooka M, Sakita I, Tamaki Y, Monden M. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary nodes by reverse transcription-polymerase chain reaction. Breast Cancer Res Treat. 1999; 58: 137140.
  • 12
    Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D. Detection of circulating mammary carcinoma cells in peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol. 1999; 17: 20152019.
  • 13
    Lin YC, Wu Chou YH, Liao IC, Cheng AJ. The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers. Cancer Lett. 2003; 191: 9399.
  • 14
    Silva JM, Dominguez G, Silva J, et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res. 2001; 7: 28212825.
  • 15
    Nunez-Villar MJ, Martinez-Arribas F, Pollan M, et al. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumor phenotype. Breast Cancer Res. 2003; 5: R65R70.
  • 16
    Lin YC, Chen SC, Hsueh S, et al. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients. Cancer Sci. 2003; 94: 99102.
  • 17
    Stachurski D, Fanger G, Xu B, et al. CRxA-01 and mammaglobin expression in breast cancer: potential role in differentiating breast cancer from other CK7+/CK20− tumors (abstract). Mod Pathol. 2003; 16: 48A.
  • 18
    Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 2003; 18: 849861.
  • 19
    Fujita J, Ohtsuki Y, Bandoh S, et al. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines. Lung Cancer. 2003; 39: 3136.